-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Glioblastoma Growth Mechanism Identified, Pointing to Potential Therapeutic Targets
A study led by Adelaide University scientists at the Centre for Cancer Biology (CCB) has uncovered a critical mechanism driving the growth and spread of glioblastoma (GBM)—one...
-
BioPharma Dive – AI / Data2 weeks agoRA Capital targets China with latest SPAC deal
The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a securities filing.
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoJudge’s Halt on RFK Jr.’s Vaccine Changes Remains in Effect, At Least for Now
Brian Murphy, a U.S. District Judge in Massachusetts, recently temporarily blocked key parts of RFK Jr.’s plan to change the U.S. childhood vaccine schedule. Judge Murphy...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Patrick Soon-Shiong, a controversial figure in the biotech industry, was harshly criticized by the U.S. Food and Drug Administration for making several false and misleading claims...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: How will Trump handle the CDC and ACIP?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
Endpoints News2 weeks ago
Ocugen heads to Phase 3 with gene therapy for geographic atrophy
Ocugen said it will take its gene therapy for a form of vision loss into a Phase 3 trial, after reporting mixed results on Tuesday from...
-
Uncategorized2 weeks agoThe next generation of CAR-T cell therapies
Drug Discovery World Editor Reece Armstrong speaks to Dr Jan Davidson-Moncada, Chief Medical Officer at Imviva Biotech about the development of CAR-T cell therapies and the company’s activities in this space. ...
-
Endpoints News2 weeks ago
Lessons from the last health tech revolution
Given his former role as US national coordinator for health IT, you might expect that Farzad Mostashari would be an AI enthusiast. But his experience overseeing...
-
Endpoints News2 weeks ago
FDA warns ImmunityBio over misleading podcast with Patrick Soon-Shiong
The FDA warned California-based ImmunityBio for a TV advertisement and podcast that gave the “misleading impression” that Anktiva, the company’s treatment for a type of bladder...
